Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTIU7X1)

• DTT Name: Herpes simplex virus DNA polymerase UL30 (HSV UL30) DTT Info
• Gene Name: HSV UL30

Molecule-Related Drug & Molecule List

10 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Aciclovir	DMYLOVR	Genital herpes	1A94	Approved	[1]
Cidofovir	DMA13GD	Cytomegalovirus infection	1D82	Approved	[1]
Cytarabine	DMZD5QR	Acute lymphoblastic leukaemia	2A85	Approved	[2]
Famciclovir	DMJHLSD	Meniere disease	AB31.0	Approved	[3]
Foscavir	DM9KJLZ	Cytomegalovirus retinitis	9B72.00	Approved	[4]
Ganciclovir	DM1MBYQ	Cytomegalovirus infection	1D82	Approved	[5]
Penciclovir	DMOUMDV	Herpes simplex labialis	1F00.01	Approved	[6]
Valaciclovir	DMHKS94	Genital herpes	1A94	Approved	[7]
Valacyclovir Hydrochloride	DM5I1CE	Herpes simplex virus infection	1F00	Approved	[1]
Valganciclovir	DMS2IUH	Virus infection	1A24-1D9Z	Approved	[4]

8 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Netivudine	DMTKRY1	Virus infection	1A24-1D9Z	Phase 3	[8]
Fialuridine	DMCIGRB	Hepatitis B virus infection	1E51.0	Phase 2	[9]
URSOLIC ACID	DM4SOAW	Metabolic syndrome x	5C50-5D2Z	Phase 2	[10]
Valomaciclovir stearate	DMAEB9O	Varicella zoster virus infection	1E91	Phase 2	[11]
GS-9219	DMTJQ8S	Solid tumour/cancer	2A00-2F9Z	Phase 1/2	[12]
BETULINIC ACID	DMBUI2A	Melanoma	2C30	Phase 1	[13]
Guanosine	DM4T5LH	N. A.	N. A.	Phase 1	[14]
ROCICLOVIR	DMDRBNJ	Virus infection	1A24-1D9Z	Phase 1	[15]

5 Discontinued Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Tomeglovir	DMY40KZ	Virus infection	1A24-1D9Z	Discontinued in Phase 2	[16]
Aphidicolin	DM71C6D	N. A.	N. A.	Discontinued in Phase 1	[17]
CHPMPC	DMJ5UYL	Virus infection	1A24-1D9Z	Discontinued in Phase 1	[18]
Amitivir	DM64YJW	Virus infection	1A24-1D9Z	Terminated	[20]
GR-95168	DMAHNF6	Virus infection	1A24-1D9Z	Terminated	[21]

1 Preclinical Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
IDX136	DMRIMZL	Hepatitis C virus infection	1E51.1	Preclinical	[19]

27 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
(+)-Myristinin A	DM7FZHI	Discovery agent	N.A.	Investigative	[22]
(+)-Myristinin D	DMEK07T	Discovery agent	N.A.	Investigative	[22]
(24E)-3beta-hydroxy-7,24-euphadien-26-oic acid	DM1RYH9	Discovery agent	N.A.	Investigative	[23]
2'-deoxythymidine triphosphate	DM9OEJT	Discovery agent	N.A.	Investigative	[24]
3-cis-p-coumaroyl maslinic acid	DM78FWG	Discovery agent	N.A.	Investigative	[13]
3-Oximo-olean-12-en-29-oic acid	DMVIRLX	Discovery agent	N.A.	Investigative	[25]
3-trans-p-coumaroyl maslinic acid	DMOQWDS	Discovery agent	N.A.	Investigative	[13]
3alpha-O-trans-p-coumaroyl-7-labden-15-oic acid	DM4M6LR	Discovery agent	N.A.	Investigative	[26]
3beta-hydroxyrus-12,19(29)-dien-28-oic acid	DML8NY0	Discovery agent	N.A.	Investigative	[10]
3beta-hydroxyrus-18,20(30)-dien-28-oic acid	DMKL59W	Discovery agent	N.A.	Investigative	[10]
5-propenyl-2'-deoxyuridine triphosphate	DM6A902	Discovery agent	N.A.	Investigative	[24]
5-propenyl-arabinofuranosyluracil 5'-triphosphate	DM762FY	Discovery agent	N.A.	Investigative	[24]
6-(3-Ethyl-phenylamino)-1H-pyrimidine-2,4-dione	DMKUHN9	Discovery agent	N.A.	Investigative	[27]
6-(4-Bromo-phenylamino)-1H-pyrimidine-2,4-dione	DMCYQDU	Discovery agent	N.A.	Investigative	[27]
6-(4-Chloro-phenylamino)-1H-pyrimidine-2,4-dione	DM5LUF4	Discovery agent	N.A.	Investigative	[27]
Alpha,beta-methylene-dATP	DMHRME4	Discovery agent	N.A.	Investigative	[28]
Alpha,beta-methylene-dCTP	DMJI8TX	Discovery agent	N.A.	Investigative	[28]
Alpha,beta-methylene-dGTP	DMPZS80	Discovery agent	N.A.	Investigative	[28]
Alpha,beta-methylene-dTTP	DMPAHJF	Discovery agent	N.A.	Investigative	[28]
DdCTP SODIUM	DMHLNA2	Discovery agent	N.A.	Investigative	[29]
Gallic acid 5,6-dihydroxy-3-carboxyphenylester	DMNWU83	Discovery agent	N.A.	Investigative	[30]
Guanosine-5'-Monophosphate	DM3SLZK	Discovery agent	N.A.	Investigative	[14]
Mahureone D	DM5WNH8	Discovery agent	N.A.	Investigative	[29]
OLEANOLIC_ACID	DMWDMJ3	Discovery agent	N.A.	Investigative	[10]
PENICILLIOL A	DMZUES2	Discovery agent	N.A.	Investigative	[31]
PMEA	DMBKVJY	Discovery agent	N.A.	Investigative	[32]
TALAROFLAVONE	DMW24JP	Discovery agent	N.A.	Investigative	[33]

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
• [2] Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage. Mol Cancer Ther. 2009 Apr;8(4):864-72.
• [3] Penciclovir cream--improved topical treatment for herpes simplex infections. Skin Pharmacol Physiol. 2004 Sep-Oct;17(5):214-8.
• [4] Drug targets in cytomegalovirus infection. Infect Disord Drug Targets. 2009 Apr;9(2):201-22.
• [5] Application of real time polymerase chain reaction to the diagnosis and treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Zhonghua Xue Ye Xue Za Zhi. 2009 Feb;30(2):77-81.
• [6] Antimicrobial strategies: inhibition of viral polymerases by 3'-hydroxyl nucleosides. Drugs. 2009;69(2):151-66.
• [7] Extensive oral shedding of human herpesvirus 8 in a renal allograft recipient. Oral Microbiol Immunol. 2009 Apr;24(2):109-15.
• [8] Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment. Drugs. 1999 Feb;57(2):187-206.
• [9] Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3592-7.
• [10] DNA polymerase beta inhibitors from Baeckea gunniana. J Nat Prod. 1999 Dec;62(12):1624-6.
• [11] Progress in the Development of New Therapies for Herpesvirus Infections. Curr Opin Virol. 2011 December 1; 1(6): 548-554.
• [12] GS-9219--a novel acyclic nucleotide analogue with potent antineoplastic activity in dogs with spontaneous non-Hodgkin's lymphoma. Clin Cancer Res. 2008 May 1;14(9):2824-32.
• [13] DNA polymerase beta inhibitors from Tetracera boiviniana. J Nat Prod. 1999 Dec;62(12):1660-3.
• [14] How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
• [15] Herpes simplex virus type 1 DNA polymerase. Mechanism of inhibition by acyclovir triphosphate. J Biol Chem. 1989 May 5;264(13):7405-11.
• [16] Focus on new drugs in development against human cytomegalovirus. Drugs. 2002;62(13):1853-8.
• [17] Proteasome regulation of ULBP1 transcription. J Immunol. 2009 May 15;182(10):6600-9.
• [18] Conversion of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine to cidofovir by an intracellular cyclic CMP phosphodiesterase.. Antimicrob Agents Chemother. 1997 March; 41(3): 641-646.
• [19] Therapy with amineptine, a dopamine reuptake inhibitor, in patients with major depression. Indian J Psychiatry. 1997 Apr;39(2):147-53.
• [20] Approaches and strategies for the treatment of influenza virus infections. Antivir Chem Chemother. 1999 Jul;10(4):155-85.
• [21] US patent application no. 2004,0023,290, Novel therapeutic agents that modulate enzymatic processes.
• [22] (+)-Myristinins A and D from Knema elegans, which inhibit DNA polymerase beta and cleave DNA. J Nat Prod. 2005 Nov;68(11):1625-8.
• [23] A new 7,8-euphadien-type triterpenoid from Brackenridgea nitida and Bleasdalea bleasdalei that inhibits DNA polymerase beta. J Nat Prod. 2000 Oct;63(10):1356-60.
• [24] Inhibition of human hepatitis B virus DNA polymerase and duck hepatitis B virus DNA polymerase by triphosphates of thymidine analogs and pharmacokinetic properties of the corresponding nucleosides. JMed Virol. 1988 Dec;26(4):353-62.
• [25] DNA polymerase beta inhibitors from Sandoricum koetjape. J Nat Prod. 1999 Aug;62(8):1110-3.
• [26] Harbinatic acid, a novel and potent DNA polymerase beta inhibitor from Hardwickia binata. J Nat Prod. 1999 Jul;62(7):1000-2.
• [27] Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils. J Med Chem. 1980 Jan;23(1):34-8.
• [28] Alpha,beta-methylene-2'-deoxynucleoside 5'-triphosphates as noncleavable substrates for DNA polymerases: isolation, characterization, and stability... J Med Chem. 2008 Oct 23;51(20):6460-70.
• [29] Acylphloroglucinol derivatives from Mahurea palustris. J Nat Prod. 2005 Jul;68(7):979-84.
• [30] Differential inhibition of reverse transcriptase and various DNA polymerases by digallic acid and its derivatives. J Nat Prod. 1990 Sep-Oct;53(5):1234-40.
• [31] Penicilliols A and B, novel inhibitors specific to mammalian Y-family DNA polymerases. Bioorg Med Chem. 2009 Mar 1;17(5):1811-6.
• [32] Herpes simplex virus-specified DNA polymerase is the target for the antiviral action of 9-(2-phosphonylmethoxyethyl)adenine. J Biol Chem. 1991 Jan 5;266(1):238-44.
• [33] 1-deoxyrubralactone, a novel specific inhibitor of families X and Y of eukaryotic DNA polymerases from a fungal strain derived from sea algae. Bioorg Med Chem. 2008 Mar 15;16(6):2939-44.